Market Cap | ₹315Cr |
ROE | -11.89% |
P/E Ratio(TTM) | -1.75 |
EPS(TTM) | -8.02 |
P/B Ratio | 0.33 |
Dividend Yield | 0.00% |
Industry P/E | 34.32 |
Book Value | 42.63 |
Debt to Equity | 0.61 |
Face Value | 1 |
Parent Organisation | Nectar Life Sciences |
Managing Director | Mr. Sanjiv Goyal |
NSE Symbol | NECLIFE |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 102.52 | ||
Emcure Pharmaceuticals | NA (0.00%) | 34.37 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.22 | ||
Wockhardt | NA (0.00%) | -152.61 |